Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD).
Kumru OS, Bajoria S, Kaur K, Hickey JM, Van Slyke G, Doering J, Berman K, Richardson C, Lien H, Kleanthous H, Mantis NJ, Joshi SB, Volkin DB. Kumru OS, et al. Among authors: hickey jm. Hum Vaccin Immunother. 2023 Aug;19(2):2264594. doi: 10.1080/21645515.2023.2264594. Epub 2023 Nov 6. Hum Vaccin Immunother. 2023. PMID: 37932241 Free PMC article.
Measurement of Adenovirus-Based Vector Heterogeneity.
Hickey JM, Jacob SI, Tait AS, Vahid FD, Barritt J, Rouse S, Douglas A, Joshi SB, Volkin DB, Bracewell DG. Hickey JM, et al. J Pharm Sci. 2023 Apr;112(4):974-984. doi: 10.1016/j.xphs.2022.12.012. Epub 2022 Dec 21. J Pharm Sci. 2023. PMID: 36563855 Free PMC article.
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
Kumru OS, Sanyal M, Friedland N, Hickey J, Joshi R, Weidenbacher P, Do J, Cheng YC, Kim PS, Joshi SB, Volkin DB. Kumru OS, et al. bioRxiv [Preprint]. 2023 Apr 4:2023.04.03.535447. doi: 10.1101/2023.04.03.535447. bioRxiv. 2023. Update in: Vaccine. 2023 Oct 20;41(44):6502-6513. doi: 10.1016/j.vaccine.2023.08.037 PMID: 37066156 Free PMC article. Updated. Preprint.
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
Kumru OS, Sanyal M, Friedland N, Hickey JM, Joshi R, Weidenbacher P, Do J, Cheng YC, Kim PS, Joshi SB, Volkin DB. Kumru OS, et al. Among authors: hickey jm. Vaccine. 2023 Oct 20;41(44):6502-6513. doi: 10.1016/j.vaccine.2023.08.037. Epub 2023 Aug 22. Vaccine. 2023. PMID: 37620203 Free PMC article.
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant.
Caringal RT, Hickey JM, Sharma N, Jerajani K, Bewaji O, Brendle S, Christensen N, Batwal S, Mahedvi M, Rao H, Dogar V, Chandrasekharan R, Shaligram U, Joshi SB, Volkin DB. Caringal RT, et al. Among authors: hickey jm. Vaccines (Basel). 2024 May 26;12(6):580. doi: 10.3390/vaccines12060580. Vaccines (Basel). 2024. PMID: 38932309 Free PMC article.
149 results